News | News By Subject | News by Disease News By Date | Search News

Alzheimer's Disease News Articles

Get Our FREE
Industry eNewsletter
Top Breaking News
Meet the 'Rock Star of Science' Obsessed With Stopping Alzheimer's     6/23/2017
BIO2017: Eli Lilly (LLY) Clinical Development Head Looks to Innovate, Continue Alzheimer’s Research     6/21/2017
BIO2017: Former UK Prime Minister Cameron Calls for More Alzheimer’s Research     6/21/2017
Is This Fake News? Neurotrope (NTRP) Alzheimer's Release Takes Weird Spin     5/5/2017
Analyzing Wild Optimism and Questionable Studies for Alzheimer’s Drug Development     4/28/2017
Some Predict Biogen (BIIB)’s Alzheimer’s Drug Will Fail     4/27/2017
Why This SoCal Pharma Could Be Your Best Bet on Alzheimer's     4/26/2017
Why Former Medivation (MDVN) CEO and a Once-Failed Alzheimer's Drug Could be a Recipe for Disaster for Axovant (AXON)     4/20/2017
Bristol-Myers Squibb (BMY) Inks Two Separate Pacts With Biogen (BIIB) and Roche (RHHBY) For a Total of Up to $1.1B     4/14/2017
A Look at Biogen (BIIB)'s Big Bet on the Holy Grail of Science—Alzheimer's     3/29/2017
Why This Alzheimer's Biotech May Not Live to See 2020     3/6/2017
Merck & Co. (MRK), Eli Lilly (LLY) Failure Puts Alzheimer's Drug Development Spotlight on Rival Genentech (RHHBY)     3/1/2017
After Merck & Co. (MRK) & Eli Lilly (LLY) Alzheimer’s Failures, A Look at 7 Companies Still on the Hunt     2/20/2017
Another Drug Bites the Dust: Merck & Co. (MRK) Stops Late-Stage Alzheimer’s Study     2/16/2017
2 Biotechs Taking on the $20 Billion Alzheimer's Market Full Force     2/15/2017

News from Around the Web
Experts Discover 3 Things That Can Protect The Brain From Alzheimer's, National Academies of Sciences, Engineering, and Medicine Study Reveals     6/26/2017
Alzheimer's Drug Leads UBS To Upgrade Biogen (BIIB)     6/21/2017
Alzheimer's Affects Twice As Many People As Estimated, And The Numbers Are Climbing, USC Alzheimer's Therapeutic Research Institute (ATRI) Study Reveals     6/16/2017
‘Mini-Me’ Brains-In-A-Dish Mimic Disease, Raise Hope For Eventual Therapies, Nature Reveals     4/27/2017
Why Too Much Sugar Is Bad For Your Brain, Boston University School of Medicine Study Reveals     4/25/2017
Hopes Up On Lasers Kindling Lost Memories In Alzheimer’s Patients, MIT Reveals     3/31/2017
New Test May Predict Onset Of Alzheimer's, UCSF Study Reveals     3/22/2017
How This Biotech Phenom Plans To Speed Up Drug Research And Cure Alzheimer's     3/8/2017
Will BACE Inhibitors Help Alzheimer's Patients?     2/24/2017
Merck & Co. (MRK)'s Alzheimer's Failure Has All Eyes and Hopes Turning to Biogen (BIIB)     2/16/2017
Alzheimer's Causes: Could Refined Sugar Lead To Dementia, Cognitive Decline?     2/14/2017
6 Unexpected Ways To Decrease Your Risk Of Alzheimer’s     2/13/2017
NeuroEM Medical Device Could Be Major Breakthrough For People With Alzheimer's, Banner Health Study Reveals     2/1/2017
From Psychedelics To Alzheimer's, 2016 Was A Good Year For Brain Science     1/3/2017
Following Eli Lilly (LLY)'s Failure, What's Next In Alzheimer's Treatments?     12/19/2016

Press Releases
Alzheon Publishes New Analyses Showing Clinical Benefit Of Tramiprosate In APOE4/4 Homozygous Patients With Mild Alzheimer’s Disease; Clinical Effects Suggest Disease Modification And Align With Beta Amyloid Oligomer Formation     6/22/2017
InSysBio Release: System Pharmacology Modelers Throw Light On Drug Discovery In Alzheimer's     6/21/2017
Cytox Raises £2.6 Million Led By Catapult Ventures To Launch Predictive Test For Alzheimer’s Disease     6/15/2017
Probiodrug AG Announces Encouraging Results Of The Phase IIa SAPHIR Study     6/12/2017
American Diabetes Association Release: African-Americans In New York City Are Two Times More Likely Than White Americans To Have Alzheimer's Disease     6/12/2017
H. Lundbeck A/S (LUN.CO) Obtains Rights To Breakthrough Research In Alzheimer’s Disease     6/6/2017
NIH Awards $1.7 Million Research Grant To Pain Therapeutics (PTIE) To Study Alzheimer’s Disease     6/5/2017
vTv Therapeutics (VTVT) Completes Enrollment Of Part B Of Pivotal Phase III STEADFAST Trial Evaluating Azeliragon For The Treatment Of Patients With Mild Alzheimer’s Disease     6/1/2017
Pain Therapeutics (PTIE) Announces Research Publication On Alzheimer’s Disease     6/1/2017
Voyager Therapeutics (VYGR) Selects Lead Clinical Candidate For Huntington’s Disease     6/1/2017
ProMis Neurosciences Designates PMN350 Its Second Lead Product For Development In Alzheimer's Disease     5/24/2017
United Neuroscience Reports Positive Phase I Results For Active Vaccine UB-311 In Alzheimer’s Disease     5/23/2017
Fisher Center for Alzheimer's Research Foundation Release: New Findings About Alzheimer's Protein Could Lead To New Drug Treatments     5/23/2017
CogState Ltd (CGS.AX) Selected As Preferred Provider To Eli Lilly (LLY)’s Alzheimer’s Disease Platform     5/17/2017
Probiodrug AG Announces Acceptance Of PQ912 Pharmacology Paper By Peer Reviewed Journal     5/16/2017